VEDA TRIALS
Live / Allowed — Notice of allowance issued (as of 30 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Jul 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98091041
- Mark type
- Stylized text
- Filed
- 18 Jul 2023
- Published for opposition
- 12 Nov 2024
- Attorney of record
- ELIZABETH OLINER
Goods and services
- Class 042 — Scientific and technological services: Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Platform as a service (PAAS) featuring computer software platforms for use in running, managing and analyzing clinical trials, namely, enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for use in managing and participating in clinical research and view data analytics, enabling site data capture, selecting configurable data collection methods with configurable options and configuring a participant-facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring non-downloadable software for use in clinical research analytics, data capture forms, electronic clinical outcome assessments (eCOA), recruitment, and electronic consent; Providing a website featuring non-downloadable software for enabling users to manage and participate in clinical research, view data analytics, enable site data capture, and screen participants for eligibility; Providing information in the field of clinical research via a website; Providing scientific research information in the field of clinical trials; none of the foregoing comprised of or consisting of the provision of healthcare or telehealth services, scheduling healthcare or telehealth appointments, or allowing a patient to access personal healthcare information for the provision of healthcare or telehealth services
Owner
- VEDA LIFE SCIENCES, INC., BOSTON, MA, US
- RH Studio 2 OpCo 53, Inc, New York, NY, US
- RH Studio 2 OpCo 53, Inc, New York, NY, US
Prosecution history
- 18 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 30 Dec 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Nov 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 13 Nov 2025 — OPPOSITION TERMINATED NO. 999999
- 13 Nov 2025 — OPPOSITION DISMISSED NO. 999999
- 03 Jul 2025 — OPPOSITION INSTITUTED NO. 999999
- 02 Jul 2025 — CASE ASSIGNED TO TTAB
- 02 Jul 2025 — NOTICE OF ALLOWANCE CANCELLED
- 02 Jul 2025 — OPPOSITION PAPERS RECEIVED AT TTAB
- 01 Jul 2025 — PETITION TO DIRECTOR GRANTED
- 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jun 2025 — TEAS RESPONSE TO PETITION INQUIRY LETTER
- 10 Jun 2025 — PETITION INQUIRY LETTER ISSUED
- 22 May 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED